Patents Assigned to Cumberland Pharmaceuticals Inc.
  • Publication number: 20110028553
    Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.
    Type: Application
    Filed: December 23, 2009
    Publication date: February 3, 2011
    Applicant: Cumberland Pharmaceuticals Inc.
    Inventors: Leo PAVLIV, Amy Dix Rock
  • Publication number: 20110028558
    Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.
    Type: Application
    Filed: July 6, 2010
    Publication date: February 3, 2011
    Applicant: Cumberland Pharmaceuticals Inc.
    Inventors: Leo PAVLIV, Amy Dix Rock
  • Publication number: 20110028557
    Abstract: Methods of treating a patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen in an amount effective to treat at least one condition in the patient chosen from pain, inflammation, and fever and to provide a clinically relevant effect on mean arterial pressure of the patients during the dosage interval comprising no increase or no statistically significant increase in mean arterial pressure.
    Type: Application
    Filed: February 3, 2010
    Publication date: February 3, 2011
    Applicant: Cumberland Pharmaceuticals Inc.
    Inventors: LEO PAVLIV, Amy Dix Rock
  • Patent number: 6727286
    Abstract: The present invention provides a pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than 1:1, as well as a method of making the same. The present invention also provides a method of treating a condition chosen from pain, inflammation, fever, and/or other conditions alleviated by ibuprofen comprising administering a pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than 1:1.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: April 27, 2004
    Assignee: Cumberland Pharmaceuticals Inc.
    Inventor: Leo Pavliv